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Abstract
Background—Framingham Risk Scores (FRS) were validated in a mostly Caucasian population.
Evaluation of subclinical atherosclerosis by carotid ultrasound may improve ascertainment of risk
in non-White populations. This study aimed to evaluate carotid intima-media thickness (cIMT)
and carotid plaquing among Mexican Americans, and to correlate these markers with coronary
risk factors and the FRS.
Methods/Results—Participants (n=141) were drawn from the Cameron County Hispanic
Cohort. Carotid artery ultrasound was performed and cIMT measured. Carotid plaque was defined
as areas of thickening >50% of the thickness of the surrounding walls. Mean age was 53.1±11.7
years (73.8% female). Most were overweight or obese (88.7%) and more than half (53.2%) had
the metabolic syndrome. One third (34.8%) had abnormal carotid ultrasound findings (either cIMT
≥75th percentile for gender and age or presence of plaque). Among those with abnormal carotid
ultrasound, the majority were classified as being at low 10-year risk for cardiovascular events.
Carotid ultrasound reclassified nearly a third of the cohort as being at high risk. This discordance
between 10-year FRS and carotid ultrasound was noted whether risk was assessed for hard
coronary events or global risk. Concordance between FRS and carotid ultrasound findings was
best when long-term (30-year) risk was assessed and no subject with an abnormal carotid
ultrasound was categorized as low risk by the 30-year FRS algorithm.
Conclusions—Integration of carotid ultrasound findings to coronary risk assessments and use of
longer term prediction models may provide better risk assessment in this minority population, with
earlier initiation of appropriate therapies.
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The Framingham Risk Score (FRS) is an established coronary risk assessment tool that has
been shown to be predictive of cardiovascular morbidity and mortality.1 However, this
scoring method was validated in a mostly Caucasian population, and evidence suggests that
absolute risk varies among different populations independently of the major risk factors.2–4
Furthermore, short-term risk assessments may not adequately define the true risk burden
especially in younger individuals and among women.5 Subclinical atherosclerosis as
determined by carotid intimal medial thickness (cIMT) and carotid atherosclerotic plaque
presence has been shown to be an independent predictor of cardiovascular risk.6–7 Recently,
Folsom et al8 suggested that cIMT and carotid plaque presence can be included in coronary
risk assessments and can be used along with the FRS to help better ascertain risk. The
presence and amount of subclinical atherosclerosis differ by race and ethnicity.9–11 In the
United States (US), the Hispanic population has almost doubled between 1990 and 2007
(9% to 15%),12 and is projected to reach 30% by the year 2050. Although usually classified
as a single ethnic group, Hispanics are actually culturally, socioeconomically, and
genetically heterogeneous with varying prevalence of coronary risk factors and extent of
subclinical atherosclerosis.13 Of the Hispanics residing in the US, Mexican Americans
represent the largest and ethnically distinct subgroup. Hence, understanding and describing
prevalent disease and defining risk burden in this minority population are important as the
racial/ethnic landscape of the US has changed since the original Framingham cohort was
studied. This study aimed to evaluate cIMT and carotid plaquing among a random
community-recruited Mexican American cohort, and to correlate these markers of




This study was approved by the Institutional Review Board of the University of Texas
Health Science Center-Houston. Study subjects were drawn from the Cameron County
Hispanic Cohort (CCHC) (n=141), recruited from randomly selected blocks according to the
2000 Census as described previously.14 The CCHC is a homogenous community-dwelling
Mexican American cohort living in Brownsville (Cameron County), Texas, a city in the
lower Rio Grande River at the US-Mexico border.
Extensive family, socioeconomic, educational and personal medical histories were obtained
using a directed questionnaire. Surveys and data collection were conducted in the
participants’ language of preference (Spanish or English) by bilingual research nurses and
field workers. Participants were asked to fast for at least 10 hours overnight before a clinic
visit at the Clinical Research Unit. Anthropometric measurements obtained included height,
weight, and waist circumference. Waist circumference (visceral adiposity) was measured at
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the level of the umbilicus to the nearest 0.2 cm, with the subject in a standing position and
breathing normally. Height was measured to the nearest 0.2 cm using a stadiometer. Body
mass index (BMI) was calculated as weight in kilograms divided by height squared in
meters (kg/m2). The average of 3 blood pressure (BP) and HR readings taken 5 minutes
apart were used. Laboratory studies performed included fasting lipid panel, hemoglobin
(Hb) A1c, fasting plasma glucose, and high sensitivity C-reactive protein (CRP). CRP levels
>10mg/L were excluded from analysis as such high levels likely represent acute illness.15
The presence of hypertension was both self-reported and measured as described below. The
subject was deemed to be hypertensive if the mean systolic blood pressure (SBP) was ≥
140mmHg or the mean diastolic blood pressure (DBP) was ≥ 90mmHg.16 Classification of
diabetes was also both self-reported and based on measurement of HbA1c (HbA1c >6.5%)
as per the latest guidelines from the American Diabetes Association.17 Smoking status was
defined as an affirmative answer to the question “Do you currently smoke cigarettes?”. BMI
was categorized according to the National Heart Lung and Blood Institute (NHLBI) with
overweight defined as a BMI ≥ 25.0 kg/m2, and obesity defined as a BMI ≥ 30.0 kg/m2.
Morbid obesity was defined as a BMI ≥ 40.0 kg/m2. Metabolic syndrome was defined
according to the criteria used by the American Heart Association and NHLBI as the
presence of at least 3 of the following: 1) elevated waist circumference (≥ 102cm in males
and ≥ 88cm in females), 2) elevated triglyceride (≥ 150 mg/dL), 3) Low high density
lipoprotein cholesterol (HDL-C) (< 40mg/dL in males and < 50mg/dL in females), 4)
elevated BP (≥ 130/85mmHg), and 5) elevated fasting glucose (≥ 100mg/dL).18
Framingham Risk Score
Three gender-specific Framingham risk equation scores were calculated based on standard
point values for each component. The 10-year coronary heart disease risk used age, total
cholesterol, HDL-C, SBP, diabetes, and smoking status.1 This risk score gives the 10 year
risk for hard coronary heart disease events, i.e., myocardial infarction or death from
coronary heart disease. In addition, FRS was also calculated using a gender-specific
multivariable risk factor algorithm to assess the 10-year general cardiovascular risk
(coronary artery disease, cerebrovascular disease, peripheral arterial disease and heart
failure).19 This FRS algorithm provides a single risk scoring system to assess an individual’s
global risk for cardiovascular disease events. Subjects were then categorized based on the
10-year FRS into 3 risk categories: low risk group (<10%), intermediate risk group (10%–
20%), or high risk group (>20%).18 Calculation of the FRS long-term (30-year) risk was
also performed.5 This long-term risk of general cardiovascular disease events includes both
hard coronary heart disease events such as coronary death and myocardial infarction, as well
as general cardiovascular disease events such as coronary insufficiency, angina, ischemic
stroke, hemorrhagic stroke, transient ischemic attack, peripheral artery disease, and heart
failure.5 Subjects older than 59 years are excluded in this analysis as this specific FRS
algorithm calculates long-term risk and was validated in subjects ages 20–59 years.5
Subjects were categorized by the 30-year FRS into 3 risk categories as recommended by
Pencina et al: low risk group (<12%), intermediate risk group (12%–40%), or high risk
group (>40%).5
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Carotid Ultrasound Evaluation of Subclinical Atherosclerosis
Carotid ultrasound studies to evaluate subclinical atherosclerosis were performed using the
Siemens Acuson X300 ultrasound system using a VF 13-5 linear array transducer. The
protocol was designed following guidelines from the American Society of
Echocardiography consensus statement on subclinical vascular disease.20 Both common
carotids were imaged from three different angles for a total of six images. Carotid plaque
presence was determined by examining the carotid bulb, its bifurcation and the carotid
branch arteries in addition to the common carotid artery. cIMT was measured using the
Carotid Analyzer software (Medical Imaging Applications, Coralville, Iowa), a semi-
automated border detection program. Measurements were made at the R-wave of the EKG
on a minimum of two clips from each side and the results were averaged. cIMT was
categorized as being either < or ≥75th percentile for age and gender.20 Carotid plaque was
defined as an area of wall thickening that was >50% of the thickness of the surrounding
wall. Abnormal carotid ultrasound was then defined as a cIMT ≥75% for age and gender
and/or presence of atherosclerotic plaque. All measurements were performed by a single
blinded expert reader. Replicate readings were performed on 5% of the cohort and the
intraclass correlation coefficient for our laboratory was 0.96.
Integration of Abnormal Carotid Ultrasound Findings and Framingham Risk Scores
Discordance between abnormal carotid ultrasound findings with FRS were computed and
defined as any subject who was classified as low or intermediate risk by FRS who had an
abnormal carotid ultrasound study, which reclassifies that subject as high risk. Concordance
was defined as an abnormal carotid ultrasound and an actual classification of high risk by
FRS.
Statistical Analysis
Data are summarized as mean and standard deviation for continuous variables and frequency
and column percentages for categorical variables. Participant demographics were stratified
by gender and evaluated using univariate analysis. Student’s t-test was used to compare
groups for continuous parametric data, the Kruskall Wallis Test for continuous
nonparametric data, and the Chi Square Test Statistic for categorical data. Pearson Product
Moment Correlation was used to evaluate associations between variables. A Chi square test
was performed to evaluate the trend in concordance between abnormal carotid ultrasound
findings and FRS. A p value <0.05 was considered significant. All analyses were performed
using SAS 9.2 TS level 1MO (SAS Institute Inc., Cary, NC).
RESULTS
Cohort Profile
A total of 141 cohort subjects had carotid ultrasound studies performed. Demographics are
listed in Table 1. Mean age was 53.1 ± 11.7 years (range 24–80 years); 73.8% (n=104) were
female. There was a high prevalence of coronary risk factors in this cohort. One in five
subjects was hypertensive (27.7%), diabetic (19.9%), or a smoker (24.1%). Women had
significantly higher total cholesterol (p=0.026), higher low density lipoprotein cholesterol
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(LDL-C) levels (p=0.022), but also higher HDL-C (p=0.007) than men. Men were more
likely to be smokers than women (40.5% versus 18.3%, p=0.006) but women had higher
BMI than men (32.3 ± 6.3 kg/m2 versus 29.9 ± 4.5 kg/m2; p=0.035) than men. Half of the
cohort had the metabolic syndrome (53.2%), and more than half were obese (58.9%); 8.5%
were morbidly obese. The majority was either overweight or obese (88.7%), and only 11.3%
had a normal BMI.
Carotid Ultrasound Findings
Representative images for cIMT (Figure 1) and carotid plaquing (Figure 2) are shown. The
mean cIMT was 0.66±0.15 mm, with no gender differences (0.70 ± 0.17 mm in men versus
0.65 ± 0.14 mm in women; p=NS). cIMT was highly correlated with age (r=0.50, p<0.001).
Mean cIMT was higher in patients with hypertension (0.72 ± 0.15 mm versus 0.64 ± 0.14
mm; p=0.007), diabetes (0.75 ± 0.20 mm versus 0.64 ± 0.13 mm; p=0.012), and those with
the metabolic syndrome (0.71 ± 0.17 mm versus 0.61 ± 0.11 mm; p<0.001), but did not
differ by smoking status. After controlling for age and gender, mean cIMT remained
significantly correlated with diabetes (p=0.006), fasting glucose levels (p<0.001), HbA1c
(p<0.001), total cholesterol (p=0.041), triglycerides (p=0.008), SBP (p=0.002), metabolic
syndrome (p=0.008), and obesity (p=0.035).
One third of the cohort (n=49; 34.8%) had abnormal carotid ultrasound findings. The
prevalence for each component was 16.8% for cIMT ≥75th percentile for age and gender,
and 23.1% for presence of atherosclerotic plaque. There were no gender differences between
these variables. Abnormal carotid ultrasound findings were more prevalent in older subjects
(p<0.001), hypertensives (p<0.001), diabetics (p=0.020), and in those with the metabolic
syndrome (p=0.002) [Table 2]. Abnormal carotid ultrasound findings were also more
prevalent in subjects with higher mean SBP (p<0.001), higher fasting plasma glucose
(p=0.041) and HbA1c (p=0.010), and those with lower education levels (p=0.004) [Table 2].
Framingham Risk Scores
Hard Coronary Heart Disease 10-Year Risk—The calculated overall cohort 10-year
risk for hard coronary heart disease events was deemed to be low with a mean FRS of 4.1 ±
5.5%. The mean 10-year FRS for coronary heart disease was significantly higher in Mexican
American men compared to women (10.2 ± 7.9% versus 2.0 ± 2.0%; p<0.001). Among
Mexican American men, 48.7% were deemed to be in the low risk group, 32.4% in the
intermediate risk group, and 18.9% were considered to be in the high risk group. In contrast,
all Mexican American women were classified in the low risk group, despite the high
prevalence of multiple risk factors in these women as described above. In this cohort, 86.5%
were deemed to be in the low risk group; however, nearly a third (32.0%) of these “low risk”
subjects actually had evidence of subclinical atherosclerosis by carotid ultrasound (Table 3).
Subjects with abnormal carotid ultrasound findings had significantly higher 10-year risk for
hard coronary heart disease events than those who had normal carotid ultrasound findings
(6.6 ± 6.6% versus 2.9 ± 4.3%, p<0.001). Among those with abnormal carotid ultrasound,
the majority (79.6%) were classified as being at low risk for coronary heart disease by FRS.
Carotid ultrasound reclassified nearly a third of the cohort (31.9%; n=45; 13 males and 32
females) as actually being at high risk for myocardial infarction or coronary death (Table 3).
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General Cardiovascular Disease 10-Year Risk—The calculated 10-year risk for
general cardiovascular disease for the cohort was higher at 9.2 ± 8.6%, but similarly places
the cohort at low risk for coronary artery disease, cerebrovascular disease, peripheral arterial
disease, and heart failure. The mean 10-year FRS for general cardiovascular disease was
significantly higher in Mexican American men compared to women (15.0 ± 10.7% versus
7.1 ± 6.6%; p<0.001). Among Mexican American men, 43.2% were deemed to be in the low
risk group, 18.9% in the intermediate risk group, and 37.8% were deemed to be in the high
risk group. Among Mexican American women, the majority (71.2%) were deemed to be in
the low risk group, while 24.0% were in the intermediate risk group, and only 4.8% were
categorized into the high risk group. In this cohort, the majority (63.8%) were deemed to be
at low risk for general cardiovascular disease in 10 years. Similarly however, 21.1% of these
“low risk” subjects actually already had evidence of subclinical atherosclerosis (Table 3).
Subjects with abnormal carotid ultrasound findings had significantly higher 10-year risk for
general cardiovascular disease than those who had normal carotid ultrasound findings (14.1
± 9.1% versus 6.5 ± 7.0%, p<0.001). Among those with abnormal carotid ultrasound, more
than a third (38.8%) were classified by FRS as being at low risk for coronary artery disease,
cerebrovascular disease, peripheral arterial disease or heart failure in 10 years. Carotid
ultrasound reclassified 25.5% of the cohort (n=36; 8 males and 28 females) as actually being
at high risk for general cardiovascular disease (Table 3).
Cardiovascular Disease 30-Year Risk—Subjects older than 59 years were excluded in
this analysis (n=55) as this FRS algorithm calculates long-term risk and was validated in
subjects ages 20–59 years.5 This subgroup has a mean age of 46.2 ±8.8 years (range 24–59
years). The calculated 30-year risk for cardiovascular disease for the cohort was 32.1 ±
21.4%, which places them at intermediate risk for general cardiovascular disease events
within 30 years. The mean 30-year FRS for general cardiovascular disease was not
significantly different between Mexican American men and women (37.8 ± 23.8% versus
30.5 ± 20.5%; p=NS). Among Mexican American men, 26.3% were deemed to be in the low
risk group, while 21.5% were in the intermediate risk group, and the majority (52.6%) were
deemed to be in the high risk group. Among Mexican American women, 16.4% were
deemed to be in the low risk group, 53.7% in the intermediate risk group, and 29.9% were
categorized into the high risk group. In this cohort, nearly half (46.5%) were deemed to be at
intermediate risk for general cardiovascular disease in 30 years (Table 3).
Subjects with abnormal carotid ultrasound findings had significantly higher 30-year risk for
general cardiovascular disease than those who had normal carotid ultrasound findings (46.8
± 16.9% versus 26.4 ± 20.3%, p<0.001). No subject with an abnormal carotid ultrasound
was classified as low risk using this FRS algorithm (Table 3). Among those who had
abnormal carotid ultrasound findings, the majority (53.3%) were classified as high risk.
Among those with an abnormal carotid ultrasound, 20.8% were classified as being at
intermediate 30-year risk for cardiovascular disease, and carotid ultrasound reclassified
these subjects (3 males and 11 females) as actually being at high risk for general
cardiovascular disease in 30 years.
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Integration of Abnormal Carotid Ultrasound Findings and Framingham Risk Scores
Among subjects with abnormal carotid ultrasound, 91.8% (n=45) had discordant results with
the 10-year FRS for hard coronary heart disease events, and concordance between an
abnormal carotid ultrasound and classification of high risk was seen in only 8.2% (n=4) of
the subjects (Figure 3). Concordance was higher when 10-year FRS for general
cardiovascular disease, and not just hard coronary events, was used, with 26.5% (n=13)
showing agreement between an abnormal carotid ultrasound and classification of high risk
by FRS. Nevertheless, the majority (73.5%; n=36) still had discordant results. Concordance
was highest when a long term risk prediction algorithm was used (Figure 3; p=0.018).
Concordance between the 30-year FRS for general cardiovascular disease and carotid
ultrasound was 66.7% (n=16) and no subject with an abnormal carotid ultrasound was
classified as low risk using this algorithm (discordance rate of 33.3%; n=8).
DISCUSSION
This study highlights the limitations of using the 10-year risk scoring by the FRS in a
homogeneous Mexican American cohort. The overall estimated 10-year risk in this cohort
was low (<10%) despite the marked prevalence of coronary risk factors, including a
prevalence of overweight and obesity of 88.7%. Furthermore, all Mexican American women
were classified in the low risk group for hard coronary heart disease events in 10 years,
despite the high prevalence of multiple risk factors in these women including an obesity
prevalence of 63.4% and a prevalence of metabolic syndrome of 51.9%. In this study, we
found that a substantial proportion of Mexican Americans who were categorized into the
low to intermediate 10-year risk group actually already had evidence of subclinical
atherosclerosis, warranting reclassification into the high risk category. This discordance
between 10-year FRS and carotid ultrasound findings was noted whether risk was assessed
for hard coronary events (myocardial infarction or coronary death) or global risk was
assessed for any cardiovascular event (development of coronary artery disease,
cerebrovascular disease, peripheral arterial disease or heart failure), although discordance
was less when global risk was considered versus only hard coronary events (73.5% versus
91.8%). Concordance between FRS and carotid ultrasound findings was best when long-
term (30-year) risk was assessed (discordance of 33.3%) and no subject with an abnormal
carotid ultrasound was categorized as low risk by the 30-year FRS algorithm. Integration of
carotid ultrasound findings to coronary risk assessments and use of longer term prediction
models may help better predict risk in this minority population, with resultant earlier
initiation of appropriate therapies.
Although the FRS is a widely used method for estimating cardiovascular risk, it has
recognized limitations, one of which is that it was derived from a mostly white Caucasian
population. The FRS has been applied with reasonable effectiveness on other minority
populations but often necessitated recalibration.2, 21–22 To our knowledge, there have been
no studies demonstrating its applicability in Mexican Americans. The FRS uses only
standard risk factors (age, gender, BP, total cholesterol, HDL cholesterol, diabetes, and
smoking), but other risk factors such as insulin resistance, overweight and obesity, and the
metabolic syndrome can contribute to the development of atherosclerosis and are highly
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prevalent among Mexican Americans; these are not accounted for in the FRS point system.
Smoking and diabetes are considered only as dichotomous variables, i.e., whether they are
absent or present, but the true burden of these risk factors is likely better described as a
continuum. There is also a highly dominant effect of age and gender in the FRS algorithm
compared to the other risk factors,23and FRS often underestimates risk in women and the
young.24
Carotid IMT has been found to predict future risk of myocardial infarction and stroke, and a
change in cIMT has been validated as a vascular marker for the progression of
atherosclerosis.25–28 Some preventive trials with lipid-lowering medications that used cIMT
as a surrogate endpoint have shown that retardation in the progression of cIMT is
accompanied by a reduction in cardiovascular endpoints.29 It has already been suggested
that noninvasive imaging can be used for subjects deemed to be at intermediate risk to help
in further stratification to decide which patients will benefit from intensification of
preventive therapy. However, FRS has been shown to have low predictive accuracy
particularly in the low risk category.30–31 Our results showed that there is a substantial
proportion of subjects in this community-based cohort who were classified into the low 10-
year risk category who warranted reclassification into the high risk category. These subjects
may actually be at a greater disadvantage than those categorized into the intermediate risk
group as being categorized into the low risk group gives both the patient and the healthcare
provider a false sense of security which then precludes initiation or intensification of life-
saving preventive therapies. Hence carotid ultrasonography may be valuable not only for the
intermediate risk patients but perhaps also for the low risk group. Classification of
individuals as low risk, who then develop a cardiovascular event, represents a failure of the
risk assessment tool used and this error needs to be regarded as a missed opportunity for
preventive care.
Global and longer-term prediction tools complement short-term risk assessments as they
provide a better estimate of the morbidity burden of coronary risk factors.32–33 Ten-year
FRS may underestimate the true risk burden in some individuals, particularly women and
the young, and they are often categorized into the low 10-year risk group for cardiovascular
events, but in reality their lifetime risk for these events is substantial.33 In this study, using
the 30-year FRS algorithm better stratified our subjects and there was better concordance
between the 30-year FRS and the carotid ultrasound findings. Furthermore, the calculated
mean 30-year FRS for the cohort was 32.1%, which places the cohort at intermediate risk for
general cardiovascular disease events within 30 years, as opposed to a classification of low
risk (4.1%) using the 10-year FRS. A long-term risk score may better motivate both
physicians and patients into instituting and adhering to recommended preventive therapies
and healthy behaviors, and may serve as a useful tool in public health education strategies.
There are some factors that may affect our results. Our sample size is small. Our cohort is
also relatively young with a predominance of women. FRS has been shown to underestimate
risk in these subgroups even among Whites.24 This is a cross-sectional study and cIMT was
only evaluated once without long term follow-up. Prospective studies are needed to
determine whether reclassification to a higher FRS category actually translates to increased
cardiac events. Longitudinal data are currently being collected and will provide this answer.
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The current study has a number of strengths one of which is the homogeneity of the cohort
studied. To fully understand prevalent risk among Hispanics, the Hispanic population needs
to be disaggregated into subgroups according to national origins and other characteristics34
as the paradoxical and conflicting findings related to health among Hispanics may reflect
aggregation error of outcomes data across widely varied subgroups.35
In summary, a substantial gap still remains in the detection of asymptomatic individuals who
ultimately develop coronary heart disease. The FRS is only moderately accurate for the
prediction of short and long term risk of manifesting a major coronary event.36 The addition
of personalized risk assessment by the noninvasive imaging of subclinical atherosclerosis
could complement currently used risk assessment tools. Carotid ultrasonography is simple
and safe, uses no radiation, is sensitive and reproducible, and is a relatively inexpensive test
that can be brought to the community to assess for the presence of subclinical
atherosclerosis. Using carotid ultrasound as a tool for motivating lifestyle changes and risk
reduction has also been shown to be effective.37 The findings in this study are particularly
relevant to future public health planning given the changing landscape of the composition of
the US population.
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Measured carotid intima-media thickness (cIMT) for one of the six angles used to calculate
an averaged cIMT. On the image, the red line is the media-adventitia border and the blue
line is the blood-intima border.
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Soft plaque in the left common carotid artery of a 72 year old female subject.
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Percent concordance and discordance between abnormal carotid ultrasound findings and
Framingham risk Scores (FRS). Numbers represent percent of participants in each category
of the FRS with abnormal carotid ultrasound findings and concordant or discordant
Framingham risk classification. Chi square test for trend showed a significant difference in
concordance between abnormal carotid ultrasound findings and the different FRS, being
highest for the 30-year FRS for general cardiovascular events (p=0.018).
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Table 1
Cohort Demographics.
Total Male Female P value*
(Males vs.
Females)






Age (years) 53.1±11.7 55.0±14.5 52.3±10.6 NS
Mean SBP (mmHg) 115.4±15.7 115.4±14.6 115.4±16.2 NS
Mean DBP (mmHg) 70.3±9.7 71.3±8.6 70.0±10.1 NS
Fasting Plasma Glucose (mg/dL) 109.1±32.1 110.3±29.6 108.6±33.1 NS
HbA1c (%) 5.0±0.9 5.3±0.9 5.0±0.9 NS
CRP (mg/L) 3.5±2.7 2.9±2.3 3.7±2.8 NS
Total Cholesterol (mg/dL) 188.6±37.2 177.0±34.3 192.2±37.5 0.026
Triglyceride (mg/dL) 139.0±68.2 157.8±85.6 132.3±59.4 NS
HDL-Cholesterol (mg/dL) 48.6±12.9 43.7±10.6 50.3±13.2 0.007
LDL-Cholesterol (mg/dL) 111.8±31.8 101.6±30.7 115.5±31.5 0.022
BMI (kg/m2) 31.7±5.9 29.9±4.5 32.3±6.3 0.035
Waist Circumference (cm) 104.3±13.1 104.1±10.4 104.3±13.9 NS
Annual Household Income (USD) $25,416.0±$24,365.8 $31,846.4±$27,948.7 $22,915.3±$22.541.7 NS
Highest Level of Education (years) 12.5±4.2 12.5±4.3 12.5±4.2 NS
Categorical variable n (%) n (%) n (%)
Smoker 34 (24.1) 15 (40.5) 19 (18.3) 0.006
Diabetic 28 (19.9) 6 (16.2) 22 (21.1) NS
Hypertensive 39 (27.7) 9 (24.3) 30 (28.8) NS
Metabolic Syndrome 75 (53.2) 21 (56.8) 54 (51.9) NS
Obese (BMI ≥30 kg/m2) 83 (58.9) 17 (45.9) 66 (63.4) NS
*
Student's t-test for continuous variables and Chi-square test for dichotomous variables.
































Continuous Variable Mean ± SD Mean ± SD
Age (years) 59.4±8.1 49.7±12.0 <0.001
Mean SBP (mmHg) 122.0±17.3 111.9±13.7 <0.001
Mean DBP (mmHg) 70.8±10.3 70.0±9.5 NS
Fasting Plasma Glucose (mg/dL) 117.6±39.2 104.2±26.7 0.041
HbA1c (%) 5.5±1.4 4.8±0.4 0.010
CRP (mg/L) 3.2±2.4 3.6±2.8 NS
Total Cholesterol (mg/dL) 193.9±39.8 185.8±35.6 NS
Triglyceride (mg/dL) 147.5±73.7 134.3±64.1 NS
HDL-Cholesterol (mg/dL) 48.1±16.1 48.8±10.9 NS
LDL-Cholesterol (mg/dL) 115.3±34.2 110.0±30.4 NS
BMI (kg/m2) 31.5±5.1 31.7±6.4 NS
Waist Circumference (cm) 103.9±11.1 104.5±14.0 NS
Annual Household Income (USD) $20,658.3±$17,138.7 $28,457.8±$27,738.8 NS
Highest Level of Education (years) 11.2±4.1 13.3±4.1 0.004
Categorical Variable n (%) n (%)
Females 32 (65.3) 72 (78.3) NS
Smoker 15 (30.6) 19 (20.6) NS
Diabetes 15 (30.6) 13 (14.1) 0.020
Hypertensive 22 (44.9) 17 (18.5) <0.001
Metabolic Syndrome 34 (69.4) 41 (44.6) 0.002
Obese (BMI ≥ 30 kg/m2) 30 (61.2) 53 (57.6) NS
*
Student's t-test for continuous variable and Chi-square test for dichotomous variable
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Table 3
Carotid Ultrasound Findings and Framingham Risk Score. Number of participants in each category of the
Framingham Risk Scores (low, intermediate, and high) related to normal or abnormal carotid ultrasound
findings.




Hard Coronary Heart Disease 10-Year Risk (n=141)
Low [n (%)] 122 (86.5) 39 (32.0) 83 (68.0)
Intermediate [n (%)] 12 (8.5) 6 (50.0) 6 (50.0)
High [n (%)] 7 (5.0) 4 (50.0) 3(42.9)
General Cardiovascular Disease 10-Year Risk (n=141)
Low [n (%)] 90 (63.8) 19 (21.1) 71 (78.9)
Intermediate [n (%)] 32 (22.7) 17 (53.1) 15 (46.9)
High [n (%)] 19 (13.5) 13 (68.4) 6 (31.6)
General Cardiovascular Disease 30-Year Risk (n=86)
Low [n (%)] 16 (18.6) 0 (0) 16 (100.0)
Intermediate [n (%)] 40 (46.5) 8 (20.0) 32 (80.0)
High [n (%)] 30 (34.9) 16 (53.3) 14 (46.7)
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